Weyer Christian 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Feb 28, 2020
Insider Transaction Report
Form 4
Weyer Christian
EVP Research and Development
Transactions
- Tax Payment
Common Stock
2020-02-27$85.39/sh−357$30,484→ 17,480 total - Sale
Common Stock
2020-02-27$87.62/sh−113$9,901→ 17,367 total
Footnotes (2)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.
- [F2]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.